Raymond James & Associates Bio Techne Corp Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Bio Techne Corp stock. As of the latest transaction made, Raymond James & Associates holds 356,597 shares of TECH stock, worth $18.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
356,597
Previous 348,140 2.43%
Holding current value
$18.3 Million
Previous $24.9 Million 14.24%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$70.96 - $82.35 $600,108 - $696,433
8,457 Added 2.43%
356,597 $28.5 Million
Q2 2024

Jul 19, 2024
BUY
$62.12 - $84.15 $866,760 - $1.17 Million
13,953 Added 4.18%
348,140 $24.9 Million
Q1 2024

Apr 22, 2024
BUY
$65.98 - $77.09 $2.36 Million - $2.75 Million
35,698 Added 11.96%
334,187 $23.5 Million
Q4 2023

Jan 16, 2024
BUY
$52.83 - $78.22 $2.22 Million - $3.28 Million
41,929 Added 16.34%
298,489 $23 Million
Q3 2023

Oct 24, 2023
BUY
$67.52 - $89.42 $1.59 Million - $2.11 Million
23,564 Added 10.11%
256,560 $17.5 Million
Q2 2023

Jul 25, 2023
BUY
$73.76 - $85.98 $634,040 - $739,084
8,596 Added 3.83%
232,996 $19 Million
Q1 2023

Apr 14, 2023
BUY
$71.62 - $86.62 $2.13 Million - $2.58 Million
29,740 Added 15.28%
224,400 $16.6 Million
Q4 2022

Feb 08, 2023
BUY
$80.67 - $352.29 $11.7 Million - $51.1 Million
145,152 Added 293.19%
194,660 $16.1 Million
Q3 2022

Oct 25, 2022
BUY
$282.54 - $391.85 $1.19 Million - $1.64 Million
4,198 Added 9.27%
49,508 $14.1 Million
Q2 2022

Aug 12, 2022
SELL
$322.67 - $449.65 $131,972 - $183,906
-409 Reduced 0.89%
45,310 $15.7 Million
Q1 2022

May 11, 2022
SELL
$353.85 - $487.79 $501,405 - $691,198
-1,417 Reduced 3.01%
45,719 $19.8 Million
Q4 2021

Feb 08, 2022
SELL
$456.15 - $525.06 $2 Million - $2.3 Million
-4,385 Reduced 8.51%
47,136 $24.4 Million
Q3 2021

Nov 02, 2021
SELL
$444.87 - $538.88 $1.82 Million - $2.2 Million
-4,090 Reduced 7.35%
51,521 $25 Million
Q2 2021

Aug 11, 2021
SELL
$387.35 - $450.26 $300,970 - $349,852
-777 Reduced 1.38%
55,611 $25 Million
Q1 2021

May 14, 2021
BUY
$314.62 - $411.0 $1.5 Million - $1.96 Million
4,771 Added 9.24%
56,388 $21.5 Million
Q4 2020

Feb 12, 2021
BUY
$246.9 - $321.87 $1.19 Million - $1.55 Million
4,829 Added 10.32%
51,617 $16.4 Million
Q3 2020

Nov 04, 2020
BUY
$232.22 - $282.96 $1.6 Million - $1.95 Million
6,892 Added 17.27%
46,788 $11.6 Million
Q2 2020

Jul 28, 2020
SELL
$185.43 - $279.56 $283,337 - $427,167
-1,528 Reduced 3.69%
39,896 $10.5 Million
Q1 2020

Apr 21, 2020
BUY
$161.17 - $221.51 $1.65 Million - $2.26 Million
10,212 Added 32.72%
41,424 $7.86 Million
Q4 2019

Feb 12, 2020
BUY
$189.68 - $222.09 $848,818 - $993,852
4,475 Added 16.74%
31,212 $6.85 Million
Q3 2019

Nov 07, 2019
BUY
$183.56 - $216.72 $529,203 - $624,803
2,883 Added 12.09%
26,737 $5.23 Million
Q2 2019

Aug 06, 2019
BUY
$188.72 - $215.43 $2,830 - $3,231
15 Added 0.06%
23,854 $4.97 Million
Q1 2019

May 06, 2019
SELL
$136.09 - $200.44 $108,735 - $160,151
-799 Reduced 3.24%
23,839 $4.73 Million
Q4 2018

Feb 11, 2019
SELL
$132.75 - $203.8 $89,340 - $137,157
-673 Reduced 2.66%
24,638 $3.57 Million
Q3 2018

Nov 14, 2018
BUY
$147.44 - $204.11 $56,764 - $78,582
385 Added 1.54%
25,311 $5.17 Million
Q2 2018

Aug 14, 2018
BUY
$144.9 - $165.58 $1.54 Million - $1.75 Million
10,595 Added 73.93%
24,926 $3.69 Million
Q1 2018

May 14, 2018
BUY
$131.46 - $151.04 $22,874 - $26,280
174 Added 1.23%
14,331 $2.17 Million
Q4 2017

Feb 14, 2018
BUY
$121.17 - $134.75 $37,562 - $41,772
310 Added 2.24%
14,157 $1.83 Million
Q3 2017

Nov 13, 2017
BUY
$113.59 - $123.78 $420,850 - $458,604
3,705 Added 36.53%
13,847 $1.67 Million
Q2 2017

Aug 14, 2017
BUY
N/A
10,142
10,142 $1.19 Million

Others Institutions Holding TECH

# of Institutions
627
Shares Held
160M
Call Options Held
90K
Put Options Held
14.2K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.02B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email